Skip to main content

User account menu

  • Log in
  • Register
  • Contact
BandwidthHigh

Language switcher

  • English
  • Français
  • Español

Main navigation

    • About us
    • Our work
    • Rationale
    • IDDO Team
    • Jobs
    • Contact us
    • Our partners
    • Governance
    • IDDO Board
    • Data Access Committee
    • Data sharing
    • Contributing data
    • Accessing data
    • IDDO data sharing registrations
    • Research themes
    • COVID-19
    • Ebola
    • Malaria
    • Visceral leishmaniasis
    • Medicine Quality
    • Antimicrobial Resistance
    • Schistosomiasis & STHs
    • Chagas Disease
    • Febrile illness
    • Scrub typhus
    • Other diseases
    • Research
    • Malaria Tracking Resistance
    • Malaria Clinical Trials Toolkit
    • COVID-19 LSR Tool
    • VL Tool
    • Medicine Quality Monitoring Globe
    • Medicine Quality Scientific Literature Surveyor
    • Febrile Illness Surveyor
    • Publications
    • Tools & resources
  • News

WWARN News

Please visit WWARN's website for regular updates on malaria and sign up for the WWARN newsletter here. 

Credit: Pearl Gan
Medics in PPE on COVID-19 ward
Wednesday, 20 July 2022

Incomplete reporting of COVID-19 disease severity criteria compromises meta-analysis

Patients affected by COVID-19 should be treated according to the severity of their disease. However, new research out today finds that not all key national or international organisations define severity in the same way.
WorldLeish7 logo
Thursday, 7 July 2022

Join IDDO at this year’s WorldLeish7 conference

Taking place in Cartagena, Colombia, the WordLeish7 Conference reunites the visceral leishmaniasis (VL) scientific and research community in-person for the first time in four-years.
mae_sot_office_and_lab_credit_joss_dimock_wellcome_images.jpg
Thursday, 23 June 2022

Field evaluation of EasyScan GO: a digital malaria microscopy device

Microscopic examination of Giemsa-stained blood films is key to quantifying and detecting malaria parasites but there can be difficulties in ensuring both a high-quality manual reading and inter-reader reliability. The EasyScan GO was developed as a potential solution to this, a microscopy device us...
IDDO infographic
Monday, 23 May 2022

IDDO’s latest newsletter is out

Find out more about what we’ve been up to in our latest newsletter. There are updates on our COVID-19 research, including our collaboration with ISARIC, which has assembled the world’s largest global database on COVID-19 clinical data.
woman_carrying_daughter_rwanda_photo_amelody_lee_world_bank.jpg
Friday, 6 May 2022

Experts emphasise the importance of cooperation in sharing data on artemisinin resistance in Africa

Drug-resistant malaria is now a critical public health emergency on a global scale. In a new editorial a diverse group of malaria researchers, including WWARN senior scientists, have highlighted that the artemisinin confirmed recently in Rwanda and Uganda is likely just the ‘tip of the spear’, with ...
Geneva Health Forum logo
Wednesday, 27 April 2022

IDDO at the Geneva Health Forum 4 May 2022

Hear from our Director, Professor Philippe Guérin, at the Geneva Health Forum’s plenary roundtable on 4 May on “Data sharing in the time of COVID-19: What works and what we need”.
ICMR, IDDO, Oxford logos
Tuesday, 29 March 2022

Indian authorities sign an MoU for a data and skill-sharing partnership between ICMR and IDDO

The Indian government’s Union Cabinet, chaired by Prime Minister Shri Narendra Modi, has approved a Memorandum of Understanding (MoU) between the Indian Council of Medical Research (ICMR) and the Infectious Diseases Data Observatory (IDDO), based at the University of Oxford.
african-dr-clinic-credit-ami-vitale-world_bank-flikr-newsletter-size_1.jpg
Monday, 28 March 2022

Artemisinin combination therapy trials need longer follow-up to detect late treatment failures for Plasmodium falciparum malaria

WWARN researchers have been assessing the recommended minimum follow-up period in capturing polymerase chain reaction (PCR)-confirmed recrudescence following treatment with fixed-dose artemisinin combination therapies (ACTs) for patients with uncomplicated Plasmodium falciparum malaria. 
Cherif Mahamoud Sama
Tuesday, 22 March 2022

Leveraging Ebola data expertise to inform global health data governance

A key expert invited to speak at WHO’s recent Health Data Governance Summit was Cherif Mahamoud Sama, a recipient of TDR’s Clinical Research and Development Fellowship (CRDF).
Charu Chaturvedi
Friday, 18 March 2022

Sharing expertise with scientific collaborators in India

Last year, the Indian Council for Medical Research (ICMR) National Institute of Malaria Research (NIMR) and IDDO began collaborating on a joint capacity building venture to train young researchers across three infectious diseases.
Clinic in Bamako
Tuesday, 8 March 2022

Largest-ever IPD meta-analysis of malaria patients to inform haemoglobin changes

A new malaria study using a very large analysis of pooled individual patient data (IPD) from more than 70,000 patients of all ages, has been published today in BMC Medicine.
dr_daniel_yilma.jpg
Wednesday, 2 March 2022

WWARN postdoc fellow led malaria workshop

IDDO/WWARN and University of Cape Town (UCT) TDR post-doctoral fellow Dr Daniel Yilma presented his latest malaria research at the recent workshop in Ethiopia.
ANTICOV logo
Monday, 28 February 2022

ANTICOV trial finds drug combination nitazoxanide + ciclesonide does not reduce risk of hospitalization in COVID-19 outpatients

KINSHASA / NAIROBI / GENEVA – 28 February 2022 – The ANTICOV platform clinical trial, launched in September 2020 in 13 African countries to identify treatments for mild and moderate cases of COVID-19, has stopped recruiting patients into one of its treatment arms, the drug combination nitazoxanide a...
School girls
Thursday, 10 February 2022

Applications open for RSTMH 2022 grant programme

Early career researchers are invited to apply for the RSTMH 2022 grant programme to help fund a one-year project on any topic related to tropical medicine and global health.
ANTICOV logo
Thursday, 10 February 2022

ANTICOV: clinical trial for COVID-19 in low-resource settings to test a new combination treatment, fluoxetine and budesonide

KINSHASA / NAIROBI / GENEVA – 8 February 2022 – The ANTICOV platform clinical trial has started the recruitment of participants to test a new promising drug combination, fluoxetine and budesonide, as an early treatment for people affected with mild-to-moderate COVID-19.
medic_doing_test_credit_arne_hoel_world_bank.jpg
Thursday, 27 January 2022

Interview with Undark about the emerging signs of antimalarial drug resistance in sub-Saharan Africa

WWARN experts recently spoke to Undark magazine about the emerging signs of antimalarial drug resistance in sub-Saharan Africa and what that means for the region. 
mother_and_children_at_health_centre_credit_chhor_sokunthea_world_bank.jpg
Wednesday, 26 January 2022

Study calls for rapid sharing of data to monitor artemisinin resistance

A new study has highlighted the need for more rapid dissemination of molecular marker data to monitor artemisinin resistance.
Professor Paul Newton
Friday, 19 November 2021

Paul Newton named ASTMH Distinguished International Fellow

Professor Paul Newton was announced new Distinguished International Fellow at the ASTMH Annual Meeting Awards Ceremony on the 17th November. This distinction formally recognises individuals who have made eminent contributions to a particular aspect of tropical medicine or hygiene.
woman in village
Thursday, 28 October 2021

Large-scale systematic review identifies research gaps in scrub typhus

A new, extensive systematic review has identified significant research gaps in the treatment of scrub typhus which could be improved by developing a database for individual participant data (IPD) to enable more detailed analyses to address important knowledge gaps such as the optimum dosing for chil...
covid19
Monday, 18 October 2021

IDDO to make its COVID-19 studies discoverable on the Vivli platform

IDDO has partnered with Vivli today, listing its COVID-19 studies on the platform to boost its reach across the global research community and increase both the speed of access and re-use of data.

Pagination

  • First page « First
  • Previous page ‹‹
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page ››
  • Last page Last »
Sign up for our newsletter Twitter LinkedinIDDO on YoutubeRSS

Footer menu

  • Cookies
  • Privacy Notice
  • Accessibility
  • Sitemap
  • Terms of use
© 2023 Infectious Diseases Data Observatory